ABCS N = 1076 | HABCS N = 152 | HEBCS N = 599 | SEARCH N = 1922 | P value* | ||||||
---|---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | |||
MDM2 SNP309 | TT | 444 | 41.3 | 55 | 36.2 | 183 | 30.6 | 774 | 40.3 | |
GT | 487 | 45.3 | 73 | 48.0 | 311 | 51.9 | 913 | 47.5 | ||
GG | 145 | 13.5 | 24 | 15.8 | 105 | 17.5 | 235 | 12.2 | < 0.001 | |
TP53 R72P | GG | 570 | 53.0 | 85 | 55.9 | 314 | 52.4 | 1052 | 54.7 | |
GC | 422 | 39.2 | 55 | 36.2 | 236 | 39.4 | 733 | 38.1 | ||
CC | 84 | 7.8 | 12 | 7.9 | 49 | 8.2 | 137 | 7.1 | 0.9 | |
Stage | 1 | 341 | 31.9 | 83 | 69.2 | 205 | 36.9 | 861 | 52.4 | |
2 | 581 | 54.4 | 36 | 30.0 | 295 | 53.1 | 713 | 43.4 | ||
3 | 146 | 13.7 | 1 | 0.8 | 56 | 10.1 | 69 | 4.2 | < 0.001 | |
Missing | 8 | 32 | 43 | 279 | ||||||
Differentiation grade | 1 | 338 | 35.8 | 9 | 8.7 | 138 | 24.6 | 368 | 25.4 | |
2 | 317 | 33.6 | 55 | 53.4 | 243 | 43.2 | 647 | 44.7 | ||
3 | 288 | 30.5 | 39 | 37.9 | 181 | 32.2 | 431 | 29.8 | < 0.001 | |
Missing | 133 | 49 | 37 | 476 | ||||||
ER status tumor | Negative | 240 | 34.2 | 18 | 15.4 | 135 | 23.2 | 175 | 19.8 | |
Positive | 461 | 65.8 | 99 | 84.6 | 446 | 76.8 | 708 | 80.2 | < 0.001 | |
Missing | 375 | 35 | 18 | 1039 | ||||||
p53 status tumor | Negative | 473 | 70.4 | 335 | 76.7 | |||||
Positive | 199 | 29.6 | 102 | 23.3 | 0.02 | |||||
Missing | 404 | 152 | 162 | 1922 | ||||||
Vital status patient | Alive | 694 | 64.5 | 129 | 84.9 | 462 | 77.1 | 1596 | 83.0 | |
Deceased, all | 382 | 35.5 | 23 | 15.1 | 137 | 22.9 | 326 | 17.0 | < 0.001 | |
Deceased, breast cancer | 337 | 20 | 105 | |||||||
Years of diagnosis | Range | 1974 to 1994 | 1997 to 2003 | 1997 to 1998 | 1991 to 1996 | |||||
Age at diagnosis | Mean ± SD | 42.8 | 5.2 | 56.8 | 11.3 | 56.4 | 12.8 | 50.1 | 7.7 | < 0.001 |
Follow-up | Mean ± SD | 10.5 | 5.7 | 6.5 | 1.9 | 7.3 | 2.1 | 6.3 | 2.1 | < 0.001 |